These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15066301)

  • 1. Clinical quality assurance for endovascular brachytherapy devices.
    Kirisits C; Stemberger A; Pokrajac B; Glogar D; Pötter R; Georg D
    Radiother Oncol; 2004 Apr; 71(1):91-8. PubMed ID: 15066301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations on detectors and quality control procedures for brachytherapy beta sources.
    Kollaard RP; Dries WJ; van Kleffens HJ; Aalbers TH; van der Marel H; Marijnissen HP; Piessens M; Schaart DR; de Vroome H
    Radiother Oncol; 2006 Feb; 78(2):223-9. PubMed ID: 16457901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a national protocol for a high activity (192)Ir brachytherapy source calibration.
    Milosević NT; Stanković J
    J BUON; 2002; 7(3):261-71. PubMed ID: 17918799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dosimetry of HDR afterloading machines with Ir-192- und Co-60-sources: comparison of different international protocols].
    Zakaria GA; Schütte W; Azhari HA
    Z Med Phys; 2010; 20(3):215-24. PubMed ID: 20638254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of off-centering on dose uniformity along and around blood vessels undergoing catheter-based intravascular brachytherapy.
    Nath R; Yue N
    Cardiovasc Radiat Med; 2004; 5(2):88-96. PubMed ID: 15464946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a phantom for the quality control of high dose rate 192Ir source used in brachytherapy.
    Ochoa R; Gómez F; Ferreira IH; Gutt F; de Almeida CE
    Radiother Oncol; 2007 Feb; 82(2):222-8. PubMed ID: 17267060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment parameters for beta and gamma devices in peripheral endovascular brachytherapy.
    Kirisits C; Pokrajac B; Berger D; Minar E; Pötter R; Georg D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1652-9. PubMed ID: 15590198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.
    Roué A; Venselaar JL; Ferreira IH; Bridier A; Van Dam J
    Radiother Oncol; 2007 Apr; 83(1):86-93. PubMed ID: 17368842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements.
    Sureka CS; Sunny CS; Subbaiah KV; Aruna P; Ganesan S
    Phys Med Biol; 2007 Jan; 52(2):525-37. PubMed ID: 17202631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance in intracoronary brachytherapy. Recommendations for determining the planning target length to avoid geographic miss.
    Schmid R; Kirisits C; Syeda B; Wexberg P; Siostrzonek P; Pokrajac B; Georg D; Glogar D; Poetter R
    Radiother Oncol; 2004 Jun; 71(3):311-8. PubMed ID: 15172147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical quality assurance for 106Ru ophthalmic applicators.
    Kaulich TW; Zurheide J; Haug T; Nüsslin F; Bamberg M
    Radiother Oncol; 2005 Jul; 76(1):86-92. PubMed ID: 15972240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation safety of personnel during catheter-based Ir-192 coronary brachytherapy.
    Jani SK; Steuterman S; Huppe GB; Chu GL
    J Invasive Cardiol; 2000 May; 12(5):286-90. PubMed ID: 10825771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency of vendor-specified activity values for ¹⁹²Ir brachytherapy sources.
    Austerlitz C; Wolfe M; Campos D; Sibata CH
    Med Dosim; 2012; 37(1):67-70. PubMed ID: 21741822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phantom investigations on CT seed imaging for interstitial brachytherapy.
    Siebert FA; De Brabandere M; Kirisits C; Kovács G; Venselaar J
    Radiother Oncol; 2007 Nov; 85(2):316-23. PubMed ID: 17884213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources.
    Marijnissen JP; Coen VL; van der Giessen WJ; de Pan C; Serruys PW; Levendag PC
    Radiother Oncol; 2004 Apr; 71(1):99-108. PubMed ID: 15066302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta dosimetry with microMOSFETs for endovascular brachytherapy.
    Drud E; Todorovic M; Schönborn T; Schmidt R
    Phys Med Biol; 2006 Dec; 51(23):5977-86. PubMed ID: 17110764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and personnel dosimetry in endovascular radiotherapy with 90Sr/90Y sources.
    Kalef-Ezra J; Bozios G; Tsekeris P; Michalis L
    Radiat Prot Dosimetry; 2005; 114(4):514-23. PubMed ID: 15941815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric characterization of GafChromic EBT film and its implication on film dosimetry quality assurance.
    Fuss M; Sturtewagen E; De Wagter C; Georg D
    Phys Med Biol; 2007 Jul; 52(14):4211-25. PubMed ID: 17664604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calibration of a TLD-100 powder dosimetric system to verify the absorbed dose to water imparted by 137Cs sources in low dose rate brachytherapy at the oncology unit in the Hospital General de Mexico.
    Alvarez Romero JT; Tovar Muñoz VM; de León BS; Oviedo JO; Barcenas LS; Milo CM; Monterrubio JM
    Radiat Prot Dosimetry; 2006; 120(1-4):95-9. PubMed ID: 16644958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose-rate brachytherapy source position quality assurance using radiochromic film.
    Evans MD; Devic S; Podgorsak EB
    Med Dosim; 2007; 32(1):13-5. PubMed ID: 17317530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.